Kyowa Kirin Co., Ltd. (KYKOF)
USD 16.05
(0.0%)
USD 16.05
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -378.83 Billion JPY | -19.92% |
| 2022 | -315.91 Billion JPY | -1.08% |
| 2021 | -312.54 Billion JPY | -16.3% |
| 2020 | -268.73 Billion JPY | -10118.14% |
| 2019 | -2.63 Billion JPY | 80.28% |
| 2018 | -13.33 Billion JPY | -12.38% |
| 2017 | -11.87 Billion JPY | -54.04% |
| 2016 | -7.7 Billion JPY | 8.22% |
| 2015 | -8.39 Billion JPY | 46.82% |
| 2014 | -15.78 Billion JPY | -12.92% |
| 2013 | -13.98 Billion JPY | 11.93% |
| 2012 | -15.87 Billion JPY | 24.47% |
| 2011 | -21.02 Billion JPY | 17.92% |
| 2010 | -25.61 Billion JPY | -51.27% |
| 2009 | -16.93 Billion JPY | -197.52% |
| 2008 | -5.69 Billion JPY | 63.89% |
| 2007 | -15.75 Billion JPY | -24.14% |
| 2006 | -12.69 Billion JPY | 43.76% |
| 2005 | -22.57 Billion JPY | -106.26% |
| 2004 | -10.94 Billion JPY | -131.85% |
| 2003 | 34.35 Billion JPY | -17.58% |
| 2002 | 41.68 Billion JPY | -45.08% |
| 2001 | 75.9 Billion JPY | -19.17% |
| 2000 | 93.89 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -290.83 Billion JPY | 0.9% |
| 2024 Q1 | -313.97 Billion JPY | 17.12% |
| 2023 Q2 | -354.35 Billion JPY | -8.07% |
| 2023 FY | -378.83 Billion JPY | -19.92% |
| 2023 Q1 | -327.89 Billion JPY | -3.79% |
| 2023 Q4 | -378.83 Billion JPY | -3.86% |
| 2023 Q3 | -364.74 Billion JPY | -2.93% |
| 2022 Q2 | -322.41 Billion JPY | -4.12% |
| 2022 FY | -315.91 Billion JPY | -1.08% |
| 2022 Q1 | -309.67 Billion JPY | 0.92% |
| 2022 Q4 | -315.91 Billion JPY | -0.79% |
| 2022 Q3 | -313.43 Billion JPY | 2.79% |
| 2021 Q2 | -278.45 Billion JPY | -2.82% |
| 2021 Q4 | -312.54 Billion JPY | 1.24% |
| 2021 FY | -312.54 Billion JPY | -16.3% |
| 2021 Q1 | -270.81 Billion JPY | 5.39% |
| 2021 Q3 | -316.48 Billion JPY | -13.66% |
| 2020 Q1 | -107.96 Billion JPY | -420.01% |
| 2020 FY | -268.73 Billion JPY | -10118.14% |
| 2020 Q2 | -243.52 Billion JPY | -125.56% |
| 2020 Q3 | -285 Billion JPY | -17.03% |
| 2020 Q4 | -286.24 Billion JPY | -0.44% |
| 2019 FY | -2.63 Billion JPY | 80.28% |
| 2019 Q4 | -20.76 Billion JPY | -72.23% |
| 2019 Q3 | -12.05 Billion JPY | -10.4% |
| 2019 Q2 | -10.91 Billion JPY | 31.5% |
| 2019 Q1 | -15.94 Billion JPY | -15.97% |
| 2018 Q4 | -13.74 Billion JPY | 4.91% |
| 2018 Q2 | -13.58 Billion JPY | -10.35% |
| 2018 FY | -13.33 Billion JPY | -12.38% |
| 2018 Q1 | -12.3 Billion JPY | -0.56% |
| 2018 Q3 | -14.45 Billion JPY | -6.45% |
| 2017 Q4 | -12.23 Billion JPY | -38.35% |
| 2017 Q3 | -8.84 Billion JPY | 14.23% |
| 2017 Q2 | -10.31 Billion JPY | 3.71% |
| 2017 FY | -11.87 Billion JPY | -54.04% |
| 2017 Q1 | -10.71 Billion JPY | -39.0% |
| 2016 Q1 | -8.4 Billion JPY | -0.08% |
| 2016 FY | -7.7 Billion JPY | 8.22% |
| 2016 Q4 | -7.7 Billion JPY | -10.37% |
| 2016 Q3 | -6.98 Billion JPY | -14.48% |
| 2016 Q2 | -6.09 Billion JPY | 27.42% |
| 2015 Q1 | -11.62 Billion JPY | 26.37% |
| 2015 Q3 | -12.44 Billion JPY | -8.75% |
| 2015 FY | -8.39 Billion JPY | 46.82% |
| 2015 Q2 | -11.44 Billion JPY | 1.58% |
| 2015 Q4 | -8.39 Billion JPY | 32.52% |
| 2014 Q3 | 17.5 Billion JPY | 278.72% |
| 2014 Q4 | -15.78 Billion JPY | -190.2% |
| 2014 FY | -15.78 Billion JPY | -12.92% |
| 2014 Q1 | -12.4 Billion JPY | 11.31% |
| 2014 Q2 | -9.79 Billion JPY | 21.02% |
| 2013 Q4 | -13.98 Billion JPY | 11.96% |
| 2013 FY | -13.98 Billion JPY | 11.93% |
| 2013 Q3 | -15.88 Billion JPY | 16.74% |
| 2013 Q1 | -17.49 Billion JPY | -10.19% |
| 2013 Q2 | -19.07 Billion JPY | -9.03% |
| 2012 FY | -15.87 Billion JPY | 24.47% |
| 2012 Q2 | -21.85 Billion JPY | 2.75% |
| 2012 Q3 | -20.82 Billion JPY | 4.71% |
| 2012 Q4 | -15.87 Billion JPY | 23.75% |
| 2012 Q1 | -22.47 Billion JPY | -6.89% |
| 2011 Q4 | -21.02 Billion JPY | 7.43% |
| 2011 FY | -21.02 Billion JPY | 17.92% |
| 2011 Q2 | -27.96 Billion JPY | 80.1% |
| 2011 Q1 | -140.58 Billion JPY | -448.87% |
| 2011 Q3 | -22.71 Billion JPY | 18.8% |
| 2010 FY | -25.61 Billion JPY | -51.27% |
| 2010 Q4 | -25.61 Billion JPY | -12.72% |
| 2010 Q3 | -22.72 Billion JPY | 19.98% |
| 2010 Q2 | -28.39 Billion JPY | -64.26% |
| 2010 Q1 | -17.28 Billion JPY | 0.0% |
| 2009 FY | -16.93 Billion JPY | -197.52% |
| 2009 Q3 | -5.17 Billion JPY | 90.74% |
| 2009 Q2 | -55.86 Billion JPY | 0.0% |
| 2008 FY | -5.69 Billion JPY | 63.89% |
| 2007 FY | -15.75 Billion JPY | -24.14% |
| 2006 FY | -12.69 Billion JPY | 43.76% |
| 2005 FY | -22.57 Billion JPY | -106.26% |
| 2004 FY | -10.94 Billion JPY | -131.85% |
| 2003 FY | 34.35 Billion JPY | -17.58% |
| 2002 FY | 41.68 Billion JPY | -45.08% |
| 2001 FY | 75.9 Billion JPY | -19.17% |
| 2000 FY | 93.89 Billion JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AstraZeneca PLC | 22.74 Billion USD | 1765.225% |
| Bristol-Myers Squibb Company PFD CONV 2 | 30 Billion USD | 1362.787% |
| CSPC Pharmaceutical Group Limited | -1.59 Billion USD | -23665.771% |
| Clarus Therapeutics Holdings, Inc. | 15.85 Million USD | 2389629.456% |
| Novartis AG | 12.95 Billion USD | 3024.245% |
| PT Kalbe Farma Tbk. | -169.7 Million USD | -223136.586% |